Hint mode is switched on Switch off
For swift navigation between sections

Regencell Bioscience Holdings

Organization name
Regencell Bioscience Holdings Ltd
Country name
Hong Kong
Country of registration
Cayman Islands
Industry
Pharmaceutical Preparation and Biotechnology
Public debt
-

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds
  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Quotes

Request sent
Access denied
Quotes provided by information providers are indicative in nature

Profile

Regencell Bioscience Holdings Ltd is an early-stage bioscience company that focuses on research, development and commercialization of Traditional Chinese Medicine (“TCM”) for the treatment of neurocognitive disorders and degeneration, specifically Attention Deficit Hyperactivity Disorder (“ADHD”) and Autism Spectrum

Awards

Documentation

IFRS/US GAAP reports

2025
2024
2023
2022
2021
Show all Hide
Authorization required
You need to request access

Stocks

Public debt by currencies

Codes

  • SIC
    2833 MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
  • CIK
    0001829667
Registration is required to get access.